| Company type | Public |
|---|---|
| Industry | Biotechnology |
| Headquarters | Yong-in , |
| Revenue | KRW 3,543 million (2009) |
| KRW 1,666 million (2009) | |
| Total assets | KRW 13,906 million (2009) |
| Website | www.genematrix.net/eng |
 |
GeneMatrix Inc is a Korean company servicing molecular diagnostics. The company is listed on KOSDAQ:109820.
Its main service is to diagnose DNA mutations based on its proprietary technology of restriction fragment mass polymorphism (RFMP).
GeneMatrix is affiliated with the Seoul National University Medical Center, the largest oncology center in Korea.